Celebrating Successful Members of the 1970 Cohort’s of Debre Zeit:
In this part of the web site, we present the highlights of some of the distinguished citizens who graduated from high school in Debre Zeit in 1970 and their offspring. This group have experienced all the unique events and interesting features of Debre Zeit. For instance, this group have rebled against an elitist classroom assignment experiment where bright students were to be collected into one or two classrooms based on their reading ability; the first to be thought all subjects in Amharic in grade 5; take a national exam at grade six level. Before this group, national level exam was only conducted at grade 8 and grade 12 level. The grade 12 matriculation is required for admission to university.
While the most important asset of a place is its people, what the place offers can also impact the outcome of its citizens. Considering the state of the library, availability of books, state of science laboratory, Like the other Debre Zeit students before and after them, one can say the success of the 1970 graduate cohort is against all odds. One can say Debre Zeit is magical!
As a start, despite: limited number of schools; inadequate books; almost nonexistence of science laboratory; far distance students must travel to get to school; diversity of background of the population, especially urban and rural students, and not so high economic status of most of the families; it is a magic that a high proportion of the students succeeded.
Hence, Debre Zeit has contributed more than its fair share of successful people like Dr. Tebabu Tessema Wubetu and his friends. Some of the high achievers are highlighted below:
Dr. Tebabu Tessema Wubetu: Distinguished Obstetrician and Genecologist and Consultant in Industrial Medicine
Dr. Tebabu Tessema Wubetu attended elementary and Secondary schools at Atse Libnedingle elementary and Princess Tenagnework Secondary School (P.T.S.S) respectively. He graduated from high school with Great Distinction and enrolled in Haile Selassie I University (currently Addis Ababa University) during the 1970-71 academic year.
His academic achievements of great distinction have enabled him to win a one-year scholarship and a hand watch engraved with the name of the late Emperor from the Haile Selassie Awards for Excellence Organization.
After completing his freshman year at the Science Faculty at Arat Kilo Campus, in 1972 he was accepted by the medical school and commenced his medical training at the Prince Mekonnen Hospital now called the Black Lion Specialized Referral Hospital managed by the Addis Ababa University.
Following the 1974 political upheaval and subsequent campaign of red terror that was unleashed by the Socialist Military Regime (Derg), he was forced to join the armed struggle with the Ethiopian Peoples’ Revolutionary Party to establish democracy in Ethiopia.
Dr. Tebabu Tessema Wubetu was re-settled in the United Kingdom. In the United Kingdom, he resumed his medical training and in 1985 completed and registered to practice Medicine as obstetrician & gynecologists. Based on his distinguished work, Dr. Tebabu Tessema Wubetu’s was elected as a Fellow of the Royal Physicians (FRCP) in 1990.
After a distinguished serves in his specialty, Dr. Tebabu Tessema Wubetu became a consultant in industrial medicine. In this new specialty, he extended his brilliant service until he retired in 2020.
He remained active in retirement serving as the founding chairman of Newcastle and surrounding area Ethiopian community; member of United Ethiopians for Peace and Reconciliation; as well as Director with the Northern Learning Trust.
Honoring his many years of outstanding and dedicated service, the Ethiopian community of Newcastle awarded Dr. Tebabu Tessema Wubetu a special honorary certificate.
Sadly Dr. Tebabu Tessema Wubetu unexpectedly and untimely passed away on November 30, 2021. He is dearly missed by all. This website is one of the ways in which we keep him alive.
Patents and Publications by Inventor Dr. Admassu Abebe
Dr Admassu Abebe is born in Debre Zeit. He attended elementary and High school in Deber Zeit. He completed his high school with Distinction in Debre Zeit in 1970. He attended Addis Abeba University and graduated from school of pharmacy with great distinction. He obtained his Masters degree from England and completed his P.H.D in Industrial Pharmacy from University of Grenoble, France. Dr. Admassu Abebe is a Senior Principal Scientist at Bristol-Myers Squibb based in New York City, New York.
Dr. Admassu Abebe’s Patents and Inventions
Patent number: 9616028b
Abstract: The present invention relates to bilayer tablet formulations comprising metformin extended release (XR) or reduced mass metformin XR formulation as the first layer, an SGLT2 inhibitor formulation as the second layer, and optionally a film coating. The present invention provides methods of preparing the bilayer tablet formulations and methods of treating diseases or disorders associated with SGLT2 activity employing the bilayer tablet formulations.
Type: Grant
Filed: May 7, 2015
Date of Patent: April 11, 2017
Assignees: AstraZeneca AB, AstraZeneca UK Limited
Inventors: Admassu Abebe, Kyle Martin, Jatin M. Patel, Divyakant Desai, Peter Timmins
Bilayer tablet formulations
Patent number: 9050258
Abstract: The present invention relates to bilayer tablet formulations comprising metformin extended release (XR) or reduced mass metformin XR formulation as the first layer, an SGLT2 inhibitor formulation as the second layer, and optionally a film coating. The present invention provides methods of preparing the bilayer tablet formulations and methods of treating diseases or disorders associated with SGLT2 activity employing the bilayer tablet formulations.
Type: Grant
Filed: August 13, 2013
Date of Patent: June 9, 2015
Assignee: AstraZeneca AB
Inventors: Admassu Abebe, Kyle Martin, Jatin M. Patel, Divyakant Desai, Peter Timmins
Bilayer tablet formulations
Patent number: 8535715
Abstract: The present invention relates to bilayer tablet formulations comprising metformin extended release (XR) or reduced mass metformin XR formulation as the first layer, an SGLT2 inhibitor formulation as the second layer, and optionally a film coating. The present invention provides methods of preparing the bilayer tablet formulations and methods of treating diseases or disorders associated with SGLT2 activity employing the bilayer tablet formulations.
Type: Grant
Filed: November 12, 2010
Date of Patent: September 17, 2013
Assignees: Bristol-Myers Squibb Company, AstraZeneca UK Limited
Inventors: Admassu Abebe, Kyle Martin, Jatin M. Patel, Divyakant Desai, Peter Timmins
Dr. Admassu Abebe’s research Publications:
Dr. Admassu Abebe’s research while affiliated with Bristol-Myers Squibb and other places.
Number of Publications: 21
Few Examples:
Evolution of the microstructure during the process of consolidation and bonding in soft granular solids
Article
Feb 2016
Bereket Yohannes, Gonzalez, Abebe[…], Alberto M Cuitiño
The evolution of microstructure during powder compaction process was investigated using a discrete particle modeling, which accounts for particle size distribution and material properties, such as plasticity, elasticity, and inter-particle bonding. The material properties were calibrated based on powder compaction experiments and validated based on…
The role of fine particles on compaction and tensile strength of pharmaceutical powders
Article
Apr 2015
Bereket Yohannes, Gonzalez, Abebe[…], Alberto M Cuitiño
The role of fine particles on compaction of powders and the resultant compact was studied experimentally. Samples of powders were prepared by successively removing fine particles from microcrystalline cellulose and lactose monohydrate powders. This method of preparing samples is unique compared to previous studies on particle size distribution, and…
Review of Bilayer Tablet Technology.
Article
Dec 2013
Admassu Abebe, Ilgaz Akseli, Omar Sprockel[…], Alberto M Cuitiño
Therapeutic strategies based on oral delivery of bilayer (and multilayer) tablets is gaining more acceptance among brand and generic products due to a confluence of factors including advanced delivery strategies, patient compliance and combination therapy. Successful manufacturing of these ever more complex systems needs to overcome a series of cha…
Axial strength test for round flat faced versus capsule shaped bilayer tablets
Article
Nov 2013
Jason Franck, Admassu Abebe, Rekha Keluskar[…], Howard Stamato
Abstract There has been increasing interest in fixed dose combination (FDC) therapy. Multi-layer tablets are a popular choice among various technologies to deliver FDCs. In most cases, round flat faced tooling is used in testing tablets as they have the simplest geometry. However, shaped tooling is more common for commercial products and may have a…
The Use of Foam in High Shear Wet Granulation: Effect of Scale up On Granules Quality Attributes
Conference Paper
Nov 2010
Niranjan Kottala, Admassu Abebe, Faranak Nikfar[…], Robert Jerzewski
High shear wet granulation is a common pharmaceutical unit operation for forming agglomerates. The API under study offered challenges during processing due to its low bulk density, low particle size, and its adhesive nature when in contact with water. To address the above challenges a new granulation process was employed whereby liquid binders are…
Patents by Inventor Dr. Taddesse Gebregiorgis





